LFTD Partners (LIFD) AI Stock Analysis

• Market Cap: $3.69M
• Dividend Yield: N/A
• Average Volume (3M): 1.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.53
• Revenue Growth: -12.70%
• EPS Growth: N/A
• Country: US
• Employees: 148
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 14,822,678
• 10 Day Avg. Volume: 3,614
• 30 Day Avg. Volume: 1,380
• PEG Ratio: >-0.01
• Price to Book (P/B): <0.01
• Price to Sales (P/S): 0.08
• P/FCF Ratio: <0.01
• Enterprise Value/Market Cap: -2.51K
• Enterprise Value/Revenue: >-0.01
• Enterprise Value/Gross Profit: >-0.01
• Enterprise Value/Ebitda: 392.27
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 55 Neutral
• Price Target: $0.21 ▼(-31.67% Downside)
• Action: Reiterated Date: 04/01/26
• Date: Action: Reiterated 04/01/26

The score is held back primarily by highly distorted and volatile financial performance (large TTM net loss and poor comparability), partially offset by improved TTM cash generation and a conservatively levered balance sheet. Technicals are modestly constructive (slightly positive MACD, neutral RSI, strong stochastic), and the low P/E adds valuation support.

Positive Factors

Conservative leverage

A low debt burden and manageable leverage provide balance-sheet flexibility, lowering refinancing and liquidity risk. This conservatively levered position supports capital allocation and operational resilience, allowing the company to fund needs or investments through volatility over the next several months.

Negative Factors

Large TTM net loss and earnings volatility

A very large TTM net loss and extreme year-over-year swings signal highly volatile, low-quality earnings. Persistent losses erode retained capital, constrain reinvestment, and undermine predictability, reducing confidence in near-term profitability and complicating multi-month operational planning.

LFTD Partners Business Overview & Revenue Model

Company Description

LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells psychedelic products under its Silly Shruum brand and hemp-derived cannabinoid products under its Urb Finest Flowers brand. The company was formerly known as Acquired ...

Read more

LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells psychedelic products under its Silly Shruum brand and hemp-derived cannabinoid products under its Urb Finest Flowers brand. The company was formerly known as Acquired ...

LFTD Partners Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Mar 2024	Dec 2022	Mar 2022
Income Statement
Total Revenue	36.92M	37.33M	51.61M	57.42M	31.66M
Gross Profit	12.37M	12.75M	19.70M	20.99M	15.94M
EBITDA	-23.59M	-1.50M	3.35M	10.31M	7.40M
Net Income	-24.86M	-1.86M	2.16M	7.20M	5.80M
Balance Sheet
Total Assets	19.27T	47.32M	51.35M	41.13M	39.42M
Cash, Cash Equivalents and Short-Term Investments	1.77T	2.15M	4.36M	3.72M	1.60M
Total Debt	1.76T	4.51M	4.49M	1.86M	1.34M
Total Liabilities	6.64T	9.81M	12.53M	6.59M	11.96M
Stockholders Equity	12.63T	37.50M	38.82M	34.54M	27.46M
Cash Flow
Free Cash Flow	1.20T	-1.27M	-150.74K	2.12M	5.25M
Operating Cash Flow	1.32T	-960.07K	638.92K	3.04M	5.62M
Investing Cash Flow	-121.64B	-479.57K	-2.52M	-916.12K	-446.65K
Financing Cash Flow	-2.58T	-770.95K	3.70M	-193.42K	-4.01M

LFTD Partners Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LIFD, the sentiment is Positive. The current price of 0.3 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.24, and above the 200-day MA of 0.26, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 58.21 is Neutral, neither overbought nor oversold. The STOCH value of 34.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LIFD.

LFTD Partners Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LIFD	55 Neutral	$3.69M	-0.11	-2.05%	―	-12.70%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
IXHL	49 Neutral	$43.60M	-4.80	-199.09%	―	-86.05%	24.17%
YCBD	45 Neutral	$7.14M	-10.73	-40.66%	―	-1.50%	80.17%
IMCC	40 Underperform	$2.25M	-0.71	-93.87%	―	-0.74%	81.49%